Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23306| Title: | Capecitabine (Xeloda): from the laboratory to the patient's home |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | *Antimetabolites, Antineoplastic/metabolism/therapeutic use,Clinical Trials, Phase I as Topic,Clinical Trials, Phase III as Topic,*Colorectal Neoplasms/drug therapy,*Deoxycytidine/*analogs & derivatives/metabolism/therapeutic use,Drug Design,Fluorouracil/analogs & derivatives,Humans,Kidney/drug effects,Liver/drug effects |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/23306 |
| ISSN: | 1533-0028 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/12453332 http://cigjournals.metapress.com/content/q7000610806j811x/fulltext.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pentheroudakis-2002-Capecitabine (Xeloda.pdf | 148.07 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
